Capula Management’s Exact Sciences EXAS Stock Holding History

Capula Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-413,170	Closed	-$42M	–	1128
2025 Q4	$42M	Buy	+413,170	New	+$33.2M	0.21%	57
2023 Q1	–	Sell	-4,246	Closed	-$210K	–	781
2022 Q4	$210K	Buy	+4,246	New	+$173K	﹤0.01%	690
2021 Q4	–	Sell	-14,767	Closed	-$1.41M	–	404
2021 Q3	$1.41M	Buy	+14,767	New	+$1.56M	0.02%	460

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Capula Management's EXAS Position: Q1 2026 in Review

Capula Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 413,170 shares — an estimated $42M sold.

Capula Management first reported a position in EXAS in Q3 2021 and held it in 3 quarters. The position peaked at $42M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Capula Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Capula Management sold 413,170 Exact Sciences shares in Q1 2026, an estimated $42M.
Capula Management first reported a position in Exact Sciences in Q3 2021 and held it in 3 quarters.
Capula Management's Exact Sciences position peaked at $42M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.